In Vitro Diagnostics Market Size, Share, & Trend Analysis | United States | 2025-2032 | MedSuite | Includes: Immunochemistry, Urinalysis, Molecular Diagnostics, and 5 more

In Vitro Diagnostics Market Size, Share, & Trend Analysis | United States | 2025-2032 | MedSuite | Includes: Immunochemistry, Urinalysis, Molecular Diagnostics, and 5 more

  • Year: 2026
  • Scope: 10 Years
  • Region: United States
  • Pages: 345
  • Published Date: 03/31/2026
  • Type: MedSuite

Product Description

Overall, the U.S. in vitro diagnostics market was valued at $23.9 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.2% to reach $31.8 billion.

The full report suite on the U.S. market for in vitro diagnostics includes immunochemistry, urinalysis, molecular diagnostics, molecular blood donor screening, hematology, hemostasis, point-of-care (POC) blood gas diagnostics and POC blood glucose monitoring.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Market Drivers & Limiters
  • Market Forecasts Until 2031, and Historical Data to 2021
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

U.S. In Vitro Diagnostics Market Trends

U.S. In Vitro Diagnostics Market Growth, 2022-2032 - iData Research

Automation and decentralized testing continue to be among the strongest market drivers in the post-COVID diagnostic environment. In the years immediately following the pandemic, major hospitals expanded their core laboratory capacity through a wave of purchases and rental agreements for high-throughput integrated systems that combined chemistry and immunochemistry on a single platform.

U.S. In Vitro Diagnostics Market Share Insights

Top U.S. In Vitro Diagnostics Market Share Leaders - iData Research

  • Cepheid was the leading company in the IVD market in 2025. The Cepheid GeneXpert® line of systems is popular throughout the industry as it provides platform consolidation and enables a wide range of tests to be run on a single machine with high walk-away time. The line includes models that are both POC and near patient.
  • bioMérieux the second-largest company in the IVD market in 2025. The company has a significant portfolio in the molecular diagnostic market, including the FilmArray near patient analyzer and SpotFire POC analyzer.
  • Abbott is the third-largest company in the IVD market in 2025. Abbott has two different departments present in this report: Abbott Diagnostics and Abbott Laboratories. In the core immunochemistry market, the company offers the Alinity ci-series and ARCHITECT platforms.

U.S. In Vitro Diagnostics Market Segmentation Summary

  • Immunochemistry Market – Further Segmented Into:
    • Setting: Core, and POC.
  • Urinalysis Market – Further Segmented Into:
    • Technology: Core Lab, and POC.
  • Molecular Diagnostics Market – Further Segmented Into:
    • Market Type: Molecular Diagnostics Instrument, Molecular Diagnostics Assay Kit, and Near-Patient Molecular Diagnostic.
  • Molecular Blood Donor Screening Market – Further Segmented Into:
    • Market Type: Analyzer, and Assay Kit.
  • Hematology Market – Further Segmented Into:
    • Market Type: Hematology Analyzer, and Hematology Reagent.
  • Hemostasis Market – Further Segmented Into:
    • Market Type: Hemostasis Analyzer, and Hemostasis Reagent.
  • POC Blood Gas Diagnostics Market – Further Segmented Into:
    • Product Type: Analyzer, and Reagent.
  • POC Blood Glucose Monitoring – Further Segmented Into:
    • Product Type: Analyzer, and Test Strip.

Research Scope Summary

Report Attribute Details
Region United States
Base Year 2025
Forecast 2026-2032
Historical Data 2022-2024
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

FREE Sample Report

Table of Contents

TABLE of CONTENTS
List of Figures
List of Charts
executive summary
U.S. In Vitro Diagnostics Market Overview
Competitive Analysis
Market Trends
Market Developments
Market Segmentation
Key Analysis Updates
Key Report Updates
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
Impact of global tariffs
U.S. In Vitro Diagnostics Market Overview
3.1 Introduction
3.2 Market Overview & Trend Analysis
3.3 Drivers and Limiters
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers and Acquisitions
Immunochemistry Market
4.1 Introduction
4.1.1 Immunoassay
4.1.2 Clinical Chemistry
4.2 Market Overview
4.3 Market Analysis and Forecast
4.3.1 Core Immunochemistry Market
4.3.1.1 Core Immunoassay Market
4.3.1.1.1 Immunoassay Analyzer Market
4.3.1.1.2 Immunoassay Reagents Market
4.3.1.2 Clinical Chemistry Market
4.3.1.2.1 Clinical Chemistry Analyzer Market
4.3.1.2.2 Clinical Chemistry Reagents Market
4.3.1.3 Integrated Immunochemistry Analyzer Market
4.3.2 POC Immunochemistry Market
4.3.2.1 POC Immunoassay Market
4.3.2.1.1 POC Immunoassay Analyzer Market
4.3.2.1.2 POC Immunoassay Reagent Market
4.3.2.2 POC Clinical Chemistry Market
4.3.2.2.1 POC Clinical Chemistry Analyzer Market
4.3.2.2.2 POC Clinical Chemistry Reagent Market
4.4 Drivers and Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
Urinalysis Market
5.1 Introduction
5.2 Market Overview
5.3 Market Analysis and Forecast
5.3.1 Core Lab Urinalysis Market
5.3.1.1 Core Lab Automated Urinalysis Analyzer Market
5.3.1.2 Core Lab Automated Urinalysis Analyzer Reagents Market
5.3.2 POC Urinalysis Market
5.3.2.1 POC Urinalysis Analyzer Market
5.3.2.2 POC Urinalysis Test Strip Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
Molecular Diagnostics Market
6.1 Introduction
6.1.1 PCR
6.1.2 Gel Electrophoresis
6.2 Market Overview
6.3 Market Analysis and Forecast
6.3.1 Molecular Diagnostics Instrument Market
6.3.1.1 Core Lab Molecular Diagnostics Analyzer Market
6.3.1.2 POC Molecular Diagnostics Analyzer Market
6.3.2 Molecular Diagnostics Assay Kit Market
6.3.2.1 Infectious Disease Molecular Diagnostics Assay Kit Market
6.3.2.1.1 Blood Borne Virus Infection Disease Molecular Diagnostics Assay Kit Market
6.3.2.1.2 Respiratory Infectious Disease Assay Molecular Diagnostics Market
6.3.2.1.3 Women’s Health Molecular Diagnostics Assay Kit Market
6.3.2.1.4 Other Infectious Disease Molecular Diagnostics Assay Kit Market
6.3.2.2 PCR Molecular Diagnostics Assay Kit Market
6.3.2.2.1 Lung Cancer PCR Molecular Diagnostics Assay Kit Market
6.3.2.2.2 Prostate Cancer PCR Molecular Diagnostics Assay Kit Market
6.3.2.2.3 Colorectal Cancer PCR Molecular Diagnostics Assay Kit Market
6.3.2.2.4 Myeloma Leukemia Molecular Diagnostics Assay Kit Market
6.3.2.2.5 Thrombophilia Assay Molecular Diagnostics Kit Market
6.3.2.1 Panel & NGS Tests Molecular Diagnostic Assay Kit Market
6.3.2.1.1 Oncology Cancer Panel & NGS Tests Market
6.3.2.1.2 Prostate Cancer Assay Market
6.3.2.1 Near Patient Molecular Diagnostic Market
6.3.2.1.1 Near Patient Molecular Diagnostic Analyzer Market
6.3.2.1.2 Near Patient Molecular Diagnostic Reagents Market
6.4 Drivers and Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis
Molecular blood donor screening MARKET
7.1 Introduction
7.1.1 Human Immunodeficiency Virus (HIV)
7.1.2 West Nile Virus (WNV)
7.1.3 Hepatitis B (HBV)
7.1.3.1 Hepatitis C (HCV)
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Molecular Blood Donor Screening Analyzer Market
7.3.2 Molecular Blood Donor Screening Assay Kit Market
7.3.2.1 WNV Molecular Blood Donor Screening Reagent Market
7.3.2.2 HIV Molecular Blood Donor Screening Reagent Market
7.3.2.1 HBV Molecular Blood Donor Screening Reagent Market
7.3.2.1 HCP Molecular Blood Donor Screening Reagent Market
7.3.2.1 Multiplex (HIV, HBV, HCV) Molecular Blood Donor Screening Reagent Market
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis
HEMATOLOGY MARKET
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Hematology Analyzer Market
8.3.1.1 High-End Hematology Analyzer Market
8.3.1.2 Low- End Hematology Analyzer Market
8.3.2 Hematology Reagent Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
HEMostasis MARKET
9.1 Introduction
9.1.1 Thrombosis
9.1.2 Hemorrhage
9.1.3 Hemophilia A and B
9.1.4 Antiphospholipid Syndrome (APS)
9.1.5 Von Willebrand Disease (vWD)
9.1.6 Diagnosis and Monitoring
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Hemostasis Analyzer Market
9.3.2 Hemostasis Reagent Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis
POC Blood Gas Diagnostics Market
10.1 Introduction
10.2 Market Overview
10.3 Market Analysis and Forecast
10.3.1 POC Blood Gas Diagnostic Analyzer Market
10.3.1.1 Handheld POC Blood Gas Diagnostic Analyzer Market
10.3.1.2 Decentralized POC Blood Gas Diagnostic Analyzer Market
10.3.2 POC Blood Gas Diagnostic Reagent Market
10.3.2.1 Single-Use Cartridge POC Blood Gas Diagnostic Reagent Market
10.3.2.2 Multi-Use Cartridge POC Blood Gas Diagnostic Reagent Market
10.3.2.1 Other Packaged Reagents and Electrode POC Blood Gas Diagnostic Reagent Market
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis
POc Blood Glucose Monitoring MARKET
11.1 Introduction
11.2 Market Overview
11.3 Market Analysis and Forecast
11.3.1 POC Blood Glucose Monitoring Analyzer Market
11.3.2 POC Blood Glucose Monitoring Test Strip Market
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis
Abbreviations

Companies Included

• Abaxis • Hemo Bioscience
• Abbott • HemoCue
• Advanced Instruments • HemoSonics
• Agendia • Heska
• ALCOR Scientific • Hologic
• Alere • HORIBA Instruments
• Alfa Wassermann • HTG Molecular Diagnostics
• Arkray USA • Illumina
• AutoGenomics • LabCorp
• Awareness Technologies • Lifescan
• Axis Shield Point of Care • Luminex
• AZER Scientific • MDxHealth
• BD • Medix
• Beckman Coulter • Medline
• Bio/Data • Meridian Bioscience
• Biocartis NV • MilliporeSigma
• BioLife Plasma Services • Mindray
• bioMérieux • National Genetics Institute
• Bio-Rad Laboratories • Nova Biomedical
• Biosite • PTS Diagnostics
• Boule Medical • QiaGen
• Cardinal Health • QuidelOrtho
• Carolina Liquid Chemistries • Radiometer America
• Cepheid • Randox Laboratories
• Cholestech • Ricca Chemical
• Chrono-Log • Roche Diagnostics
• Diagnostica Stago • Sebia Electrophoresis
• DiaSorin • Siemens Healthineers
• Drew Scientific • StemCell Tech
• EKF Diagnostics • Sysmex America
• ELITech • Thermo Fisher Scientific
• Fresenius Med USA • Tosoh Bioscience
• Generic Label • Trividia Health
• GenMark Diagnostics • Universal Biosensors
• Grifols USA • Vital Diagnostics
• Haemonetics • Werfen
• Helena Laboratories

Chart List

Chart 1‑1: In Vitro Diagnostics Market by Segment, U.S., 2025 – 2032
Chart 1‑2: In Vitro Diagnostics Market Overview, U.S., 2025 & 2032
Chart 3‑1: In Vitro Diagnostics Market by Segment, U.S., 2022 – 2032
Chart 3‑2: Leading Competitors, In Vitro Diagnostics Market, U.S., 2025
Chart 4‑1: Immunochemistry Market by Segment, U.S., 2022 – 2032
Chart 4‑2: Leading Competitors, Immunochemistry Market, U.S., 2025
Chart 5‑1: Urinalysis Market by Segment, U.S., 2022 – 2032
Chart 5‑2: Leading Competitors, Urinalysis Market, U.S., 2025
Chart 6‑1: Molecular Diagnostics Market by Segment, U.S., 2022 – 2032
Chart 6‑2: Leading Competitors, Molecular Diagnostics Market, U.S., 2025
Chart 7‑1: Molecular Blood Donor Screening Market by Segment, U.S., 2022 – 2032
Chart 7‑2: Leading Competitors, Hematology Market, U.S., 2025
Chart 8‑1: Hematology Market by Segment, U.S., 2022 – 2032
Chart 8‑2: Leading Competitors, Hematology Market, U.S., 2025
Chart 9‑1: Hemostasis Market by Segment, U.S., 2022 – 2032
Chart 9‑2: Leading Competitors, Hemostasis Market, U.S., 2025
Chart 10‑1: POC Blood Gas Diagnostics Market by Segment, U.S., 2022 – 2032
Chart 10‑2: Leading Competitors, POC Blood Gas Diagnostics Market, U.S., 2025
Chart 11‑1: POC Blood Glucose Monitoring Market by Segment, U.S., 2022 – 2032
Chart 11‑2: Leading Competitors, POC Blood Glucose Monitoring Market, U.S., 2025

Figure List

Figure 1‑1: In Vitro Diagnostics Market Share Ranking by Segment, U.S., 2025 (1 of 2)
Figure 1‑2: In Vitro Diagnostics Market Share Ranking by Segment, U.S., 2025 (2 of 2)
Figure 1‑3: Companies Researched in this Report (1 of 2)
Figure 1‑4: Companies Researched in this Report (2 of 2)
Figure 1‑5: Factors Impacting the In Vitro Diagnostics Market by Segment, U.S. (1 of 2)
Figure 1‑6: Factors Impacting the In Vitro Diagnostics Market by Segment, U.S. (2 of 2)
Figure 1‑7: Recent Events in the In Vitro Diagnostics Market, U.S., 2022 – 2026 (1 of 2)
Figure 1‑8: Recent Events in the In Vitro Diagnostics Market, U.S., 2022 – 2026 (2 of 2)
Figure 1‑9: In Vitro Diagnostics Markets Covered (1 of 3)
Figure 1‑10: In Vitro Diagnostics Markets Covered (2 of 3)
Figure 1‑11: In Vitro Diagnostics Markets Covered (3 of 3)
Figure 1‑12: Key Analysis Updates
Figure 1‑13: Key Report Updates
Figure 1‑14: Version History
Figure 3‑1: In Vitro Diagnostics Market by Segment, U.S., 2022 – 2032 (US$M) (1 of 2)
Figure 3‑2: In Vitro Diagnostics Market by Segment, U.S., 2022 – 2032 (US$M) (2 of 2)
Figure 3‑3: Leading Competitors, In Vitro Diagnostics Market, U.S., 2025 (1 of 2)
Figure 3‑4: Leading Competitors, In Vitro Diagnostics Market, U.S., 2025 (2 of 2)
Figure 4‑1: Immunochemistry Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 4‑2: Core Immunochemistry Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 4‑3: Core Immunoassay Market by Segment, U.S., 2022 – 2032
Figure 4‑4: Immunoassay Analyzer Market by Segment, U.S., 2022 – 2032
Figure 4‑5: Immunoassay Analyzer Market, U.S., 2022 – 2032
Figure 4‑6: High Volume Immunoassay Analyzer Market, U.S., 2022 – 2032
Figure 4‑7: Low-Mid Volume Immunoassay Analyzer Market, U.S., 2022 – 2032
Figure 4‑8: Immunoassay Reagents Market, U.S., 2022 – 2032
Figure 4‑9: Cardiovascular Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑10: Cancer Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑11: Infectious Disease Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑12: Vitamin D Testing Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑13: Endocrinology Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑14: Reproductive and Fertility Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑15: Autoimmune Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑16: Clinical Chemistry Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 4‑17: Clinical Chemistry Analyzer Market by Segment, U.S., 2022 – 2032
Figure 4‑18: High-Volume Laboratory Clinical Chemistry Analyzer Market, U.S., 2022 – 2032
Figure 4‑19: Low Volume Laboratory Clinical Chemistry Analyzer Market, U.S., 2022 – 2032
Figure 4‑20: Clinical Chemistry Reagents Market, U.S., 2022 – 2032
Figure 4‑21: General Chemistry Clinical Chemistry Reagent Market, U.S., 2022 – 2032
Figure 4‑22: Specific Protein Clinical Chemistry Reagent Market, U.S., 2022 – 2032
Figure 4‑23: Therapeutic Drug Monitoring Clinical Chemistry Reagent Market, U.S., 2022 – 2032
Figure 4‑24: Drugs of Abuse / Toxicology Clinical Chemistry Reagent Market, U.S., 2022 – 2032
Figure 4‑25: Special Chemistry Clinical Chemistry Reagent Market, U.S., 2022 – 2032
Figure 4‑26: Integrated Immunochemistry Analyzer Market, U.S., 2022 – 2032
Figure 4‑27: POC Immunochemistry Market by Segment, U.S., 2022 – 2032
Figure 4‑28: POC Immunoassay Market by Segment, U.S., 2022 – 2032
Figure 4‑29: POC Immunoassay Analyzer Market, U.S., 2022 – 2032
Figure 4‑30: POC Immunoassay Reagent Market by Segment, U.S., 2022 – 2032
Figure 4‑31: POC Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑32: Sars-Cov2 POC Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑33: Influenza POC Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑34: Multiplex POC Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑35: Cardiac POC Immunoassay Reagent Market, U.S., 2022 – 2032
Figure 4‑36: POC Clinical Chemistry Market by Segment, U.S., 2022 – 2032
Figure 4‑37: POC Clinical Chemistry Analyzer Market, U.S., 2022 – 2032
Figure 4‑38: POC Clinical Chemistry Reagent Market, U.S., 2022 – 2032
Figure 4‑39: Leading Competitors, Immunochemistry Market, U.S., 2025
Figure 5‑1: Urinalysis Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 5‑2: Core Lab Urinalysis Market by Segment, U.S., 2022 – 2032
Figure 5‑3: Core Lab Automated Urinalysis Analyzer Market, U.S., 2022 – 2032
Figure 5‑4: Core Lab Automated Urinalysis Analyzer Reagents Market, U.S., 2022 – 2032
Figure 5‑5: POC Urinalysis Market by Segment, U.S., 2022 – 2032
Figure 5‑6: POC Urinalysis Analyzer Market, U.S., 2022 – 2032
Figure 5‑7: POC Urinalysis Test Strip Market, U.S., 2022 – 2032
Figure 5‑8: Leading Competitors, Urinalysis Market, U.S., 2025
Figure 6‑1: Molecular Diagnostics Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 6‑2: Molecular Diagnostics Instrument Market by Segment, U.S., 2022 – 2032
Figure 6‑3: Molecular Diagnostics Instrument Market, U.S., 2022 – 2032
Figure 6‑4: Core Lab Molecular Diagnostics Analyzer Market, U.S., 2022 – 2032
Figure 6‑5: POC Molecular Diagnostics Analyzer Market, U.S., 2022 – 2032
Figure 6‑6: Molecular Diagnostics Assay Kit Market by Segment, U.S., 2022 – 2032
Figure 6‑7: Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑8: Infectious Disease Molecular Diagnostics Assay Kit Market by Segment, U.S., 2022 – 2032
Figure 6‑9: Infectious Disease Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑10: Blood Borne Virus Infection Disease Molecular Diagnostics Assay Kit Market by Segment, U.S., 2022 – 2032
Figure 6‑11: Blood Borne Virus Infection Disease Molecular Diagnostics Market, U.S., 2022 – 2032
Figure 6‑12: HIV Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑13: HCV Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑14: HBV Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑15: Respiratory Infectious Disease Assay Molecular Diagnostics Market, U.S., 2022 – 2032
Figure 6‑16: Women’s Health Molecular Diagnostics Assay Kit Market by Segment, U.S., 2022 – 2032
Figure 6‑17: Women’s Health Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑18: HPV Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑19: HSV Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑20: CT/GC Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑21: Other Infectious Disease Molecular Diagnostics Assay Kit Market by Segment, U.S., 2022 – 2032
Figure 6‑22: Other Infectious Disease Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑23: MRSA Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑24: C. difficile Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑25: PCR Molecular Diagnostics Assay Kit Market by Segment, U.S., 2022 – 2032
Figure 6‑26: PCR Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑27: Lung Cancer PCR Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑28: Prostate Cancer PCR Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑29: Colorectal Cancer PCR Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑30: Myeloma Leukemia Molecular Diagnostics Assay Kit Market, U.S., 2022 – 2032
Figure 6‑31: Thrombophilia Assay Molecular Diagnostics Kit Market, U.S., 2022 – 2032
Figure 6‑32: Panel & NGS Tests Assay Kit Market by Segment, U.S., 2022 – 2032
Figure 6‑33: Panel & NGS Tests Assay Kit Market, U.S., 2022 – 2032
Figure 6‑34: Oncology Cancer Panel & NGS Tests Market, U.S., 2022 – 2032
Figure 6‑35: Prostate Cancer Assay Market, U.S., 2022 – 2032
Figure 6‑36: Near Patient Molecular Diagnostic Market by Segment, U.S., 2022 – 2032
Figure 6‑37: Near Patient Molecular Diagnostic Analyzer Market, U.S., 2022 – 2032
Figure 6‑38: Near Patient Molecular Diagnostic Reagents Market by Segment, U.S., 2022 – 2032
Figure 6‑39: Near Patient Molecular Diagnostic Reagents Market, U.S., 2022 – 2032
Figure 6‑40: Sars Cov2 Cartridge Market, U.S., 2022 – 2032
Figure 6‑41: Multiplex Respiratory Market, U.S., 2022 – 2032
Figure 6‑42: Influenza Cartridge Market, U.S., 2022 – 2032
Figure 6‑43: Leading Competitors, Molecular Diagnostics Market, U.S., 2025
Figure 7‑1: Molecular Blood Donor Screening Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 7‑2: Molecular Blood Donor Screening Analyzer Market, U.S., 2022 – 2032
Figure 7‑3: Molecular Blood Donor Screening Reagent Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 7‑4: Total Molecular Blood Donor Screening Reagent Market, U.S., 2022 – 2032
Figure 7‑5: WNV Molecular Blood Donor Screening Reagent Market, U.S., 2022 – 2032
Figure 7‑6: HIV Molecular Blood Donor Screening Reagent Market, U.S., 2022 – 2032
Figure 7‑7: HBV Molecular Blood Donor Screening Reagent Market, U.S., 2022 – 2032
Figure 7‑8: HCV Molecular Blood Donor Screening Reagent Market, U.S., 2022 – 2032
Figure 7‑9: Multiplex (HIV, HBV, HCV) Molecular Blood Donor Screening Reagent Market, U.S., 2022 – 2032
Figure 7‑10: Leading Competitors, Molecular Blood Donor Screening Market, U.S., 2025
Figure 8‑1: Hematology Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 8‑2: Hematology Analyzer Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 8‑3: Total Hematology Analyzer Market, U.S., 2022 – 2032
Figure 8‑4: High-End Hematology Analyzer Market, U.S., 2022 – 2032
Figure 8‑5: Low-End Hematology Analyzer Market, U.S., 2022 – 2032
Figure 8‑6: Hematology Reagent Market, U.S., 2022 – 2032
Figure 8‑7: Leading Competitors, Hematology Market, U.S., 2025
Figure 9‑1: Hemostasis Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 9‑2: Hemostasis Analyzer Market, U.S., 2022 – 2032
Figure 9‑3: Hemostasis Reagent Market, U.S., 2022 – 2032
Figure 9‑4: Leading Competitors, Hemostasis Market, U.S., 2025
Figure 10‑1: POC Blood Gas Diagnostics Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 10‑2: POC Blood Gas Diagnostic Analyzer Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 10‑3: Total POC Blood Gas Diagnostic Analyzer Market, U.S., 2022 – 2032
Figure 10‑4: Handheld POC Blood Gas Diagnostic Analyzer Market, U.S., 2022 – 2032
Figure 10‑5: Decentralized POC Blood Gas Diagnostic Analyzer Market, U.S., 2022 – 2032
Figure 10‑6: POC Blood Gas Diagnostic Reagent Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 10‑7: Total POC Blood Gas Diagnostic Reagent Market, U.S., 2022 – 2032
Figure 10‑8: Single-Use Cartridge POC Blood Gas Diagnostic Reagent Market, U.S., 2022 – 2032
Figure 10‑9: Multi-Use Cartridge POC Blood Gas Diagnostic Reagent Market, U.S., 2022 – 2032
Figure 10‑10: Other Packaged Reagents and Electrode POC Blood Gas Diagnostic Reagent Market, U.S., 2022 – 2032
Figure 10‑11: Leading Competitors, POC Blood Gas Diagnostics Market, U.S., 2025
Figure 11‑1: POC Blood Glucose Monitoring Market by Segment, U.S., 2022 – 2032 (US$M)
Figure 11‑2: POC Blood Glucose Monitoring Analyzer Market, U.S., 2022 – 2032
Figure 11‑3: POC Blood Glucose Monitoring Test Strip Market, U.S., 2022 – 2032
Figure 11‑4: Leading Competitors, POC Blood Glucose Monitoring Market, U.S., 2025

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Report Options

License Type

Select the access level that fits your organization:

Get a Quote Request Report Sample

Related Reports

+

GET A QUOTE

+

REQUEST REPORT SAMPLE

+

REQUEST CUSTOMIZATION

+

Free Sample Report Form

+

See Report Summary